Teladoc Health, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TDOC research report →
Companywww.teladochealth.com
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
- CEO
- Charles Divita
- IPO
- 2015
- Employees
- 4,620
- HQ
- Purchase, NY, US
Price Chart
Valuation
- Market Cap
- $1.17B
- P/E
- -6.78
- P/S
- 0.47
- P/B
- 0.87
- EV/EBITDA
- 22.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 65.62%
- Op Margin
- -7.60%
- Net Margin
- -6.81%
- ROE
- -12.37%
- ROIC
- -7.35%
Growth & Income
- Revenue
- $2.53B · -1.54%
- Net Income
- $-200,322,000 · 79.99%
- EPS
- $-1.14 · 80.58%
- Op Income
- $-262,955,000
- FCF YoY
- 0.91%
Performance & Tape
- 52W High
- $9.77
- 52W Low
- $4.40
- 50D MA
- $5.83
- 200D MA
- $6.80
- Beta
- 2.08
- Avg Volume
- 5.43M
Get TickerSpark's AI analysis on TDOC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 1, 26 | Catapano Joseph Ronald | other | 2,083 |
| Apr 1, 26 | Catapano Joseph Ronald | other | 2,083 |
| Apr 2, 26 | Catapano Joseph Ronald | sell | 675 |
| Mar 30, 26 | SALKA SUSAN R | other | 48,638 |
| Mar 30, 26 | SALKA SUSAN R | other | 0 |
| Feb 27, 26 | Bliss Kelly | other | 15,596 |
| Feb 27, 26 | Bliss Kelly | other | 5,198 |
| Mar 10, 26 | DIVITA CHARLES III | other | 25,493 |
| Mar 10, 26 | DIVITA CHARLES III | other | 39,160 |
| Mar 11, 26 | DIVITA CHARLES III | sell | 27,731 |
Our TDOC Coverage
We haven't published any research on TDOC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TDOC Report →